Analysis of the side effects and adverse reaction treatment methods of Mobosetinib (Anvili)

1. Overview of Mobosetinib

Mobocertinib is an oral targeted drug that is a selective inhibitor of epidermal growth factor receptor (EGFR) exon 20 insertion mutations. It is intended to be used to treat patients with advanced or metastatic EGFRexon20 insertion mutation-positive non-small cell lung cancer (NSCLC). Its mechanism of action is to specifically inhibit the EGFR signaling pathway, thereby blocking the proliferation and survival of tumor cells. Compared with traditional chemotherapy, mobosetinib can provide a more precise treatment plan, but like other targeted drugs, side effects and adverse reactions may still occur during its use.

2. Common side effects and occurrence characteristics

Clinical research and practice show that common side effects of moboxetinib mainly include the following categories:

1.Gastrointestinal reactions: nausea, vomiting, diarrhea, loss of appetite, etc. are the most common. Diarrhea has a higher incidence rate and sometimes affects the patient's daily life.

2.Skin reactions: rash, itching, hand-foot syndrome, etc. These side effects usually appear in the early stages of treatment, are mostly mild to moderate, and can be alleviated through local care.

3. Hematological abnormalities: Some patients experience thrombocytopenia, anemia or neutropenia, and regular blood routine monitoring is required, especially when combined with medication or long-term medication.

4.Abnormal liver function: ALT, AST Increases are potential laboratory index abnormalities. Some patients may have jaundice or significantly elevated transaminase, and liver function needs to be closely followed up.

5.Other reactions: fatigue, weakness, stomatitis or mild edema, etc., are also common adverse reactions, and most of them can be alleviated through symptomatic treatment.

These side effects usually appear in the early stages of treatment. As the medication time is prolonged, most patients can gradually adapt to the medication, but some serious reactions still require professional intervention.

3. Side effects treatment and intervention strategies

There are systematic clinical treatments for the side effects of mobosetinib:

1.Gastrointestinal reaction management:

Mild diarrhea can be relieved by rehydration, oral electrolytes, and a low-fat, low-fiber diet.

For moderate or severe diarrhea, oral antidiarrheal drugs (such as loperamide) or temporary dose adjustment may be considered.

For nausea and vomiting, anti-vomiting drugs (such as ondansetron or granisetron) can be supplemented, and it is recommended to divide meals or eat small and frequent meals.

2.Skin reaction management:

Topical moisturizers or low-concentration topical corticosteroids can be used to relieve itching and rash.

Hand-foot syndrome can be relieved by reducing friction, soaking in warm water, and applying topical care.

Severe rashes or ulcers require discontinuation of the medication and evaluation by a dermatologist, who may adjust the dose or discontinue the medication if necessary.

3.Handling of hematology abnormalities:

Routine blood tests need to be monitored regularly to detect thrombocytopenia, anemia or neutropenia in a timely manner.

Mild to moderate abnormalities can be managed with observation or supportive care such as iron supplementation, folic acid, or growth factors.

Severe hematological abnormalities require temporary discontinuation or dose reduction, close follow-up, and hospitalization if necessary.

4.Treatment of abnormal liver function:

Monitor ALT, AST and bilirubin levels regularly during treatment.

Mild increases can be observed, but severe increases or jaundice require discontinuation of the drug and liver-protective treatment.

After the liver function returns to normal after re-examination, you can consider restarting the medication or adjusting the dose under the guidance of a doctor.

5.Other adverse reaction treatments:

Fatigue can be improved with moderate rest, proper diet, and exercise.

Stomatitis and oral ulcers can be supplemented with oral care and topical anti-inflammatory drugs.

Mild edema usually does not require special treatment, but severe edema requires evaluation of cardiac and renal function and adjustment of medication.

4. Clinical medication recommendations and follow-up

During the treatment of mobosetinib, patients should strictly follow the doctor's instructions to take the drug daily and maintain regular medication. At the same time, a standardized follow-up system should be established, including blood routine, liver and kidney function, blood pressure, weight and symptom assessment, so as to detect and deal with adverse reactions early. For patients who experience severe side effects, doctors can adjust the dosage, use intermittent medication, or combine symptomatic treatment according to the specific situation.

In addition, patients and their families should be familiar with common side effects and self-monitoring methods, such as recording the number of diarrhea, rash changes, and fatigue levels every day, so as to provide accurate information when seeing a doctor. Through standardized monitoring and timely intervention, most side effects can be effectively controlled while ensuring the therapeutic efficacy of mobosetinib for advanced EGFRexons20Insertion mutationsNSCLC patients have improved long-term survival and quality of life.

Reference link:https://www.drugs.com